We are live on ! Find out more
SBBP

Strongbridge Biopharma plc.
SBBP

Delisted

SBBP was delisted on the 5th of October, 2021.

Back to rankings

54 hedge funds and large institutions have $64.8M invested in Strongbridge Biopharma plc. in 2019 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 23 increasing their positions, 13 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 13

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

7% less funds holding

Funds holding: 58 → 54 (-4)

26% less capital invested

Capital invested by funds: $87.2M → $64.8M (-$22.3M)

36% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 11

Holders
54
Holders Change
-4
Holders Change %
-6.9%
% of All Funds
1.18%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
23
Reduced
13
Closed
11
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$1.28M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.01M
3
Northern Trust
Northern Trust
Illinois
+$818K
4
BlackRock
BlackRock
New York
+$614K
5
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$577K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$4.95M
2
OM
Opaleye Management
Massachusetts
-$1.75M
3
SCM
Stonepine Capital Management
Oregon
-$508K
4
BFM
Boothbay Fund Management
New York
-$376K
5
Jane Street
Jane Street
New York
-$257K
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
1
Caxton Corporation
New Jersey
$15.8M – – –
NMC
2
NEA Management Company
Maryland
$9.9M – – –
BC
3
Broadfin Capital
New York
$6.16M +$89.1K +33,164 +1%
PM
4
Prosight Management
Texas
$6.01M -$85.7K -31,925 -1%
BlackRock
5
BlackRock
New York
$6.01M +$614K +228,765 +10%
Hudson Bay Capital Management
6
Hudson Bay Capital Management
Connecticut
$3.52M +$577K +215,000 +17%
6CM
7
683 Capital Management
New York
$2.21M – – –
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$2.15M -$137K -50,848 -5%
2L
9
22NW LP
Washington
$1.92M – – –
State Street
10
State Street
Massachusetts
$1.52M +$171K +63,759 +11%
OM
11
Opaleye Management
Massachusetts
$1.17M -$1.75M -650,000 -57%
Point72 Asset Management
12
Point72 Asset Management
Connecticut
$1.14M +$1.28M +475,000 New
Vanguard Group
13
Vanguard Group
Pennsylvania
$1.1M +$1.01M +377,747 +460%
EIM
14
Essex Investment Management
Massachusetts
$992K -$125K -46,553 -10%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$847K +$374K +139,294 +65%
Northern Trust
16
Northern Trust
Illinois
$802K +$818K +304,613 +990%
Millennium Management
17
Millennium Management
New York
$581K +$513K +191,035 +366%
Renaissance Technologies
18
Renaissance Technologies
New York
$494K +$109K +40,500 +24%
PC
19
PA Capital
Virginia
$366K +$411K +152,977 New
Bank of New York Mellon
20
Bank of New York Mellon
New York
$233K -$8.78K -3,268 -3%
TAF
21
Tredje AP-fonden
Sweden
$209K -$170K -63,235 -42%
Wells Fargo
22
Wells Fargo
California
$204K +$86.5K +32,211 +60%
Charles Schwab
23
Charles Schwab
California
$180K – – –
California State Teachers Retirement System (CalSTRS)
24
California State Teachers Retirement System (CalSTRS)
California
$133K – – –
PPA
25
Parametric Portfolio Associates
Washington
$118K +$36.2K +13,480 +38%
1
2 3

SBBP Hedge Fund Activity: Q3 2019 in Review

54 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Strongbridge Biopharma plc. (SBBP) for Q3 2019, worth a combined $64.8M — down 26% from $87.2M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of SBBP and 7 opened new positions — a net loss of 4 holders — while 13 trimmed existing stakes and 23 added.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $1.28M. The largest seller was Armistice Capital, exiting entirely with an estimated $4.95M sold.

  • 54 institutional investors held Strongbridge Biopharma plc. (SBBP) as of Q3 2019, down from 58 in Q2 2019.
  • Funds reported $64.8M of Strongbridge Biopharma plc. stock for Q3 2019, down 26% quarter-over-quarter.
  • 7 funds opened new Strongbridge Biopharma plc. positions in Q3 2019 and 11 closed out, a net change of -4 holders.
  • The largest Strongbridge Biopharma plc. buyer in Q3 2019 was Point72 Asset Management, an estimated $1.28M added.
  • The largest Strongbridge Biopharma plc. seller in Q3 2019 was Armistice Capital, an estimated $4.95M sold.

Based on aggregated 13F filings for Q3 2019.